« Return to News | Drug Sponsors

Lilly expects original drugs sales to triple in India

Friday, September 16, 2011 11:15 AM

American drug maker Eli Lilly will bet on its original drugs as it aims to triple sales in India over the next five years. Unlike other foreign drug makers, it plans to stay away from acquisition of local firms or branded generics to boost its market share, according to The Economic Times.

Eli Lilly India CEO Sandeep Gupta said that instead of buying "a slew of branded generics" the company would consider selective alliances or collaborations to complement its portfolio. He said the company might consider an alliance for anti-diabetes oral hypoglycaemic agents (capsules or tablets), a segment in which it does not have a presence.

In July, the company had tied up with Mumbai-based Lupin, which will promote and distribute Eli Lilly's insulin range. Globally, the firm tied up with German drugmaker Boehringer Ingelheim earlier this year.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.